News from neurologylive.comFollowNews from neurologylive.comSee all of neurologylive.com’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.We’ve discovered 391 headlines written by neurologylive.com during the past 3 months. Ground News rates neurologylive.com’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. neurologylive.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.Follow See all of neurologylive.com’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources. We’ve discovered 391 headlines written by neurologylive.com during the past 3 months. Ground News rates neurologylive.com’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. neurologylive.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check. Information about neurologylive.comWhere is neurologylive.com located?neurologylive.com's WebsiteMedia Bias RatingsDo you diasgree? Edit biasLearn more about Media Bias Ratings.FactualityAverage Factuality Rating: UnknownLearn more about Factuality Ratings.Top neurologylive.com NewsInnovationStrivePD: Revolutionizing Parkinson Disease Care Through Data and PersonalizationAmanda Hare, DNP, a doctor of nursing practice specialized in movement disorders, gave comments on the innovation behind the StrivePD app and how it can revolutionize personalized treatment management for patients with Parkinson disease.See the StorySanta Clara · Santa ClaraRedesigning Clinical Trials in Alzheimer Disease to Promote Diversity and AccessibilityJessica Langbaum, PhD, the senior director of research strategy at Banner Alzheimer’s Institute, discussed the challenges and opportunities in improving diversity in Alzheimer disease clinical trials.See the StoryParkinson's Disease · MarylandParkinson Agent Solengepras Enters Phase 3, Sage to Discontinue SAGE-718, Serious Adverse Event Reported in Gene Therapy Study of NGN-401Neurology News Network. for the week ending November 23, 2024. [WATCH TIME: 4 minutes]See the StoryLatest News StoriesTopics Most Covered by neurologylive.comParkinson's DiseaseMultiple SclerosisDisabilityFDAHealthParkinson's DiseaseMultiple SclerosisDisabilitySources Covering Similar TopicspipelinereviewPharmacy Timescontemporarypediatrics.comlifesciencesbc.cahcplive.compipelinereviewPharmacy Timescontemporarypediatrics.comSuggest a sourceLooking for a source we don't already have? Suggest one here.You've scrolled to the bottom of the feed, there are no more stories.
